The Thirteenth International Conference on Mitochondrial Targeting This year it will be held at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany and online from October 26 to 28.
Targeting mitochondrial 2022 will bring up many hot topics related to mitochondrial function and dysfunction in health and disease. All topics will be provided by Selected speakers.
Here are some of the speaker topics related to mitochondrial targeting 2022: Mitochondrial signalsAnd the Mitochondrial diseasesAnd the cancerAnd the Cardiovascular disease (brain attack), sepsisAnd the fatty liver diseaseAnd the respiratory system diseasesAnd the schizophreniaAnd the Brain injuries and neurological diseasesAnd the agingGenetic/metabolic disorders, Extracellular vesicles and mitochondrial dysfunctionsAnd the Treatment of extracellular vesiclesAnd the Mitochondrial medicineAnd the Mitochondrial transplantAnd the Mitochondrial transportAnd the Mitochondrial genome engineeringAnd the conversion therapyAnd the Optical medicineAnd the infrared lightAnd the Mitochondria and vision…
You can get an idea about attendees.
Among the goals of mitochondrial 2022 supportersRemedies: Peppermint, Chondrion BV, and CureMito Foundation.
Presentation of abstracts
- Deadline for short oral presentations: October 7
- Poster Submission Deadline: October 14
More details about Abstract submission.
Best Mitochondrial Photo Contest
The best mitochondrial image 2022 will be selected during the conference and the winner will receive a free registration to target mitochondria 2023.
Registration for both in-person and online participation is possible. Registration details.
Deadline for early bird registration: August 31.
Targeting Mitochondrial Speakers 2022:
Douglas C. WallaceAnd the Children’s Hospital of Philadelphia, USA – Keynote Speech – Mitochondrial Medicine: Present and Future
James McCauley, Boston Children’s Hospital, USA – Recent advances in mitochondrial transplantation therapy
Jan SmitnikGondryon B, The Netherlands – Phase 2b Randomized Controlled Trial of Sonlicromanol’s KHENERGYZE in Primary Mitochondrial Diseases MELAS Spectrum Disorders: Topline Results
Laurie PullmanUniversity of the Midwest, Glendale, USA – Folic acid supplementation improves the Drosophila parkin loss-of-function phenotype and reduces mitochondrial hydrogen peroxide levels in impaired dopaminergic neurons.
Michael WeberPresident of the European Laser Academy, Germany – Mitochondrial and imaging medicine – modern clinical applications
Mark GermanAnd the University of Quebec at Trois-Rivieres, Canada – The role of extracellular vesicles in mitochondrial quality control mechanisms
Enas, servant of GodLausanne University Hospital, Switzerland – Mitochondria, exosomal miR137-COX6A2 in Schizophrenia
Cora and changedUniversity Hospital Tübingen, Germany – Exercise and adaptations of mitochondria and fatty liver
Pedro Silva Pinheiro University of Cambridge, UK – The potential for mitochondrial genome engineering
Maria FazariUniversity of Milan, Italy – GM1 oligosaccharide as a mitochondrial modifier: implications for neurodegenerative disease
Lefkothea C PapadopoulouAnd the Aristotle University of Thessaloniki, Greece – A novel PTD-mediated IVT-mRNA delivery platform developed for protein replacement therapy of genetic/metabolic disorders
Devika S ManikamAnd the Duquesne University, USA – EV-Mitochondria as a promising treatment for mitochondrial dysfunction
Jessica SpinelliWhitehead Institute for Biomedical Research, USA – Unlocking the potential of the electron transport chain in mammals
Mark JeschkeUniversity of Toronto, Canada – Mitochondrial responses to massive shock determined for survival
Ian J HoltBiodonostia Institute for Health Research, Spain – 2-Deoxy-D-glucose pairs mitochondrial DNA replication with mitochondrial fitness
Michael TeitelAnd the University of California, USA – Mitochondrial transfer via MitoPunch
Raghavan Pillai RajuAnd the Medical College of Georgia, USA – Targeting mitochondria in aging and injury
Camila VolAnd the University of Padova, Italy – The multiple facets of the mitochondrial-forming protein Opa1 in adipocytes: from epigenetic to histological plasticity.
Kon Sophia Zhang, Loyola University Chicago Campus for Health Sciences, USA – Regulation of mitochondrial signaling in cardiomyopathy during sepsis
Julia A VoorholtETH Zurich, Switzerland – Transplantation of mitochondria between living cells
Big ArnoldMemorial Sloan Kettering Cancer Center, USA – The uncharacterized carboxylic acid cycle determines cellular identity
Mike Hotman, Wayne State University, USA – Noninvasive treatment of cerebral ischemia-reperfusion injury with near-infrared light: work on clinical implementation
Melanie Walker University of Washington College of Medicine, USA – Autologous mitochondrial transplantation for cerebral ischemia
Anna KrasnodemskayaQueen’s University Belfast, UK – Effect of mesenchymal extracellular vesicles on mitochondrial dysfunction in acute respiratory distress syndrome
Nicole Noreen HoughtonNational Institutes of Health, USA – Mitochondria in extracellular vesicles and aging
Diane Chandra Roswell Park Comprehensive Cancer Center, USA – Targeting the unfolded mitochondrial response to protein in prostate cancer
John Paulfrom the National Institute of Health, USA – Mitochondria in the photoreceptors in the retina: More than meets the eye
About the World Mitochondrial Society:
The World Mitochondrial Society has emerged seamlessly from a series of annual conferences organized since 2010 by the International Society of Antioxidants in Nutrition and Health. The current chair of WMS is Volkmar Weissig, Midwestern University, Glendale School of Pharmacy, USA.
For more information visit the WMS website: www.wms-site.com.
Disclaimer: AAAS and EurekAlert! Not responsible for the accuracy of newsletters sent to EurekAlert! Through the contributing institutions or for the use of any information through the EurekAlert system.